Google Alert - in

	in As-it-happens update ⋅ 5 November 2020
	WEB
	Lynparza approved in the EU for the treatment of BRCA-mutated metastatic castration-resistant ... AstraZeneca Prostate cancer is the second-most common type of cancer in men, with an estimated 1.3 million patients diagnosed worldwide in 2018.1 Approximately ... Flag as irrelevant

You have received this email because you have subscribed to Google Alerts. Unsubscribe

Receive this alert as RSS feed

Send Feedback

ShareThis